Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | M. Masià-Balagué et al., J. Biol. Chem., Jun 2015; 290: 15197 - 15209 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | K. Albert et al., Mol. Therapy, 2021, 29: 9, doi.org/10.1016/j.ymthe.2021.04.035 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | M. Pretze et al., J. Med. Chem., 2016, 59: 9855−9865; DOI:10.1021/acs.jmedchem.6b01191 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. Ansems et al., J Natl Cancer Inst, Jan 2010; 102: 54 - 68 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | C. Karl et al., J Neurochemistry, 2005, 92, 264-282 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | application note | ![]() |
||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | H. C. Kim et al., SLAS Discovery, 2017, 22 (8): 1053 -1059, doi.org/10.1177/2472555217699823 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | A. Shumilov et al., Nature Communications, 8:14257, DOI: 10.1038/ncomms14257 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | A. Jain et al., J. Biol. Chem., Jul 2010; 285: 22576 - 22591 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | W. Neuhofer et al., Frontiers in Physiol., 5 , article 123, doi: 10.3389/fphys.2014.00123 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | J. Schulz et al., Scientific Reports, 2018, 8: 2395, DOI:10.1038/s41598-018-19201-8 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | H. K. Arnold et al., Mol. Cell. Biol., Apr 2006; 26: 2832 - 2844 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | L. Hoa et al., Cellular Signalling, 2016, 28: 488-497; doi.org/10.1016/j.cellsig.2016.02.012 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | S. Yoo et al., EMBO J., Apr 2011; 30: 1593 - 1607 | Link | ||
HEK293 (s) |
Human embryonic kidney cell line (suspension) | ATCC CRL-1573 | Human | urinary system | cell line | suspension | plasmid | Metafectene | application note | ![]() |
|||
HEK293 (s) |
Human embryonic kidney cell line (suspension) | ATCC CRL-1573 | Human | urinary system | cell line | suspension | plasmid | Metafectene PRO | application note | ![]() |
|||
HEK293 (s) |
Human embryonic kidney cell line (suspension) | ATCC CRL-1573 | Human | urinary system | cell line | suspension | plasmid | K2 Transfection System | application note | ![]() |
|||
HEK293 (s) |
Human embryonic kidney cell line (suspension) | ATCC CRL-1573 | Human | urinary system | cell line | suspension | plasmid | Metafectene | application note | ![]() |
|||
HEK293 EBNA |
Human embryonic kidney cell line stably expressing Epstein-Barr viral nuclear antigen (EBNA) (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | antibody production | Metafectene PRO | application note | ![]() |
|||
HEK293 EBNA |
Human embryonic kidney cell line stably expressing Epstein-Barr viral nuclear antigen (EBNA) (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. Granato et al., J. Virol., Nov 2014; 88: 12715 - 12726. | Link | |||
HEK293 EBNA1 |
Human embryonic kidney cell line stably expressing Epstein-Barr viral nuclear antigen 1 (EBNA1) (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | O. Gires et al., Anticancer Res, Nov 2004; 24: 3715 - 3722 | Link | ||
HEK293 F |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
HEK293-D2089 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | V. Mordasini et al., Oncotarget, 2017, 8 ( 4): 6461-6474 | Link | ||
HEK293-rB95.8 |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | J. Rac et al., PLoS ONE, 2015, 10(4): e0123645; doi:10.1371/journal.pone.0123645 | Link |